New York Stock

[U.S. Featured Stocks] Ford Barely Holds onto Third Place in U.S. Auto Sales… HyundaiMotor Hot on Its Heels

Ahn Hye-shin
2026-10-03 00:48:16
[Edaily Reporter Ahn Hye-shin ] Ford Motor (F) has barely managed to hold onto its third-place position in U.S. auto sales.

As of 11:41 a.m. on the 2nd (local time), Ford shares were trading at $12.05, down 1.83% ($0.22) from the previous trading day.

Ford announced that its third-quarter vehicle sales totaled 507,395 units, a 6.6% decrease from the previous year. This figure excludes sales of large trucks. This result narrowly surpasses HyundaiMotor’s third-quarter sales of 506,200 units. HyundaiMotor(005380) ’s sales increased by 5.4% year-over-year. HyundaiMotor’s sales figure combines sales from the Hyundai, KIA CORPORATION, and Genesis brands.

On a cumulative basis through the third quarter, Ford’s sales were approximately 89,700 units ahead of HyundaiMotor’s.

Ford has been struggling to produce its flagship F-Series pickup trucks following two fires at parts suppliers last year that disrupted production and sales.

However, Ford downplayed HyundaiMotor’s sales figures, stating, “Although they share the same parent company under corporate governance, the Kia and Hyundai brands are operated separately in the U.S.” In other words, Ford expressed dissatisfaction with the practice of grouping HyundaiMotor and KIA CORPORATION—which compete as separate, independent legal entities and brands in the U.S.—under a single “HyundaiMotor” umbrella for direct comparison with Ford.

Economy

Corporation

IT·Science

Economy

[Economy with the EU] Making Clothes Without Water… European VCs Bet on Innovation in Fashion Manufacturing

In the European fashion-tech market, global investors’ interest is expanding beyond eco-friendly materials to include innovations in production processes. With the emergence of technologies that can r…
2026-10-08 19:43:03

Corporation

DAE HWA PHARM CO., LTD Receives Additional Approval in China for “Liporacel Solution,” an Oral Anticancer Drug, for the Treatment of Breast Cancer

Daehwa Pharmaceutical ( DAE HWA PHARM CO., LTD(067080)) announced on the 8th that its oral anticancer drug “Liporaxel” (Liporaxel, active ingredient DHP107/RMX3001) has received approval from China’s …
2026-10-08 19:01:02

IT·Science

SKT Launches ‘Token Gateway’… Deploys AI Talent to ‘Frontier’

With the rapid surge in AI usage, SKTelecom—noting the potential for the rise of a “token economy”—is launching its “Token Gateway” business. While connecting telecommunications, AI services, and infr…
2026-10-08 17:49:14